• Why choose Olink for targeted protein biomarker discovery?

    • High quality data that you can trust
    • The rapid high throughput analysis that your studies deserve
    • The most effective use of your precious samples
  • Proseek multiplex for protein biomarker discovery

Testimonials

  • We are impressed by the quality of data delivered by the Olink technology with very small sample sizes. The application in the field of precision medicine is extremely promising.

    Professor Mathias Uhlen, Science for Life Laboratory & Royal Institute of Technology (KTH), Stockholm
  • Olink's Immunoassay panels are very useful tools for targeting and discovering protein dynamics in our longitudinal studies, such as the integrative personal omics profile (iPOP).

    Professor Mike Snyder, Department of Genetics, Stanford University
  • The Olink panel provided some directions we wouldn’t have considered previously, and is a very appealing strategy for neuroscience projects hoping to identify novel CSF biomarkers.

    Tom Lanz, Principal Scientist, Pfizer Neuroscience
  • It is critical that scientists have a proteomics service that is based on reliable analytical systems, provides effective data management and delivers expert post-analysis technical support. I am happy to say that Olink Proteomics emphatically delivers all these elements.

    Dr John Taylor, Centre for Oral Health Research, Newcastle University, UK

Product news (Dec 14, 2017)

Now available – Olink’s first mouse protein biomarker panel

We are pleased to announce the launch of Olink® MOUSE EXPLORATORY, our first protein biomarker panel developed for use in mouse studies. It enables the analysis of 92 mouse proteins simultaneously, consuming just 1 µL of sample. The human counterparts of these proteins are known to be detectable in serum and plasma, increasing the likelihood that any findings made in mice can be readily investigated in human studies.

Share in our company vision!

View the video and see where Olink Proteomics is today (at the forefront of targeted protein biomarker discovery), and where we see our future, in the development  of precision diagnostics and the realization of precision medicine.